Sign in

CIK 0001505497 · Non-accelerated filer<br>Smaller reporting company

BioRestorative Therapies, Inc.

Sign in to watch
Ticker
BRTX
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
301341024
Phone
(631) 760-8100
Business address
40 MARCUS DRIVE, SUITE ONE, MELVILLE, NY
Former names
Stem Cell Assurance, Inc.
  1. 8-K Event Unregistered share sale
  2. 4 Open-market buy EVP and Chief Strategy Officer bought 20,000 shares at an average $0.26 ($5,220)
  3. S-1/A Offering Registration Statement
  4. 8-K Event Unregistered share sale · Shareholder vote results · Regulation FD disclosure
  5. 4 Open-market buy EVP and Chief Strategy Officer bought 10,000 shares at an average $0.27 ($2,698)
  6. 4 Open-market buy VP of Research and Development bought 20,955 shares at an average $0.24 ($5,018)
  7. 4 Open-market buy CEO and Chairman of the Board bought 22,000 shares at an average $0.25 ($5,530)
  8. 4 Open-market buy VP of Research and Development bought 18,000 shares at an average $0.28 ($4,990)
  9. 4 Open-market buy Director bought 17,850 shares at $0.28 ($4,918)
  10. 4 Open-market buy Director bought 70,000 shares at an average $0.27 ($19,180)
  11. 4 Open-market buy Director bought 6,000 shares at an average $0.27 ($1,650)
  12. 4 Open-market buy CEO and Chairman of the Board bought 10,000 shares at an average $0.26 ($2,608)
  13. 4 Open-market buy VP of Research and Development bought 7,500 shares at an average $0.27 ($2,015)
  14. 4 Open-market buy EVP and Chief Strategy Officer bought 10,000 shares at an average $0.28 ($2,761)
  15. 4 Open-market buy Director bought 6,000 shares at an average $0.26 ($1,540)
  16. 8-K Event Unregistered share sale
  17. 4 Open-market buy VP of Research and Development bought 17,374 shares at an average $0.26 ($4,446)
  18. 4 Open-market buy 10% owner bought 175,017 shares at an average $0.28 ($49,164)
  19. 4 Open-market buy CEO and Chairman of the Board bought 5,000 shares at an average $0.26 ($1,312)
  20. 4 Open-market buy EVP and Chief Strategy Officer bought 10,000 shares at an average $0.25 ($2,498)

Page 19 of 38 · 755 filings